Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) - Hoibraaten, E; Qvigstad, E; Arnesen, H (Thromb Haemost, 2000)
et al.